Featured Research

from universities, journals, and other organizations

New DNA technique leads to a breakthrough in child cancer research

Date:
February 22, 2010
Source:
University of Gothenburg
Summary:
Researchers have used novel technology to reveal the different genetic patterns of neuroblastoma, an aggressive form of childhood cancer. The discovery may lead to significant advances in the treatment of this malignant disease, which mainly affects small children.

Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden and Karolinska Institutet have used novel technology to reveal the different genetic patterns of neuroblastoma, an aggressive form of childhood cancer. This discovery may lead to significant advances in the treatment of this malignant disease, which mainly affects small children.

The article is being published in the Proceedings of the National Academy of Sciences (PNAS). The study includes 165 children with neuroblastoma, most of whom developed the disease before the age of five. These children have been monitored for over 20 years by two research teams led by professors Tommy Martinsson, of the Sahlgrenska Academy, and Per Kogner of Karolinska Institutet.

Neuroblastoma is a nerve cell cancer that has defects in certain chromosomes. If the tumour has a characteristic defect on chromosome 11, it is very aggressive and difficult to cure.

"We found that the children who develop this type of neuroblastoma are twice as old at the onset of the disease as children who develop other types of neuroblastoma. This type progresses more slowly and is more difficult to treat," says Helena Carén, a researcher at the Department of Clinical Genetics at the Sahlgrenska Academy.

By using the latest genetic techniques, the researchers have succeeded in analysing the DNA of tumour cells and identifying chromosomal defects, enabling the identification of sub-groups of the most aggressive neuroblastomas. The next step is to identify their weak points genetically in order to develop better treatment.

"We call this personalized medicine, because the treatment is based on the genetic profile of the patient, or in this case, of the tumour cells," says Tommy Martinsson, professor of genetics at the Department of Clinical Genetics at the Sahlgrenska Academy.

Per Kogner, professor of paediatric oncology at Karolinska Institutet, reiterates that their discovery will now allow a variety of tailor-made treatments to be developed, saving the lives of more children.

"The analytical method we have used in our research is already being used for clinical assessment of every neuroblastoma tumour in the country, which means that we can now make more accurate diagnoses," says Helena Carén.

The study was carried out with the support of the Swedish Childhood Cancer Foundation and the Swedish Cancer Society.

About Neuroblastoma

Neuroblastoma is a form of cancer that affects small children, most of whom are diagnosed before they reach their fifth birthday. It is the third commonest form of cancer in children, after leukaemia and brain tumours. About 20 Swedish children are affected every year, and the risk of developing the disease is the same worldwide. Neuroblastoma is a tumour of nerve cells. It appears during the development phase of the sympathetic nervous system. Children may have no symptoms at all, and sometimes a lump is the first sign of the disease noticed by parents or doctors. As the tumour grows or spreads, it may press on other organs and cause symptoms. The available treatments include surgery, chemotherapy, radiotherapy, high-dose therapy combined with stem cell support, and vitamin A.


Story Source:

The above story is based on materials provided by University of Gothenburg. Note: Materials may be edited for content and length.


Journal Reference:

  1. Helena Carén, Hanna Kryh, Maria Nethander, Rose-Marie Sjöberg, Catarina Träger, Staffan Nilsson, Jonas. High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset. Proceedings of the National Academy of Sciences, 2010; DOI: 10.1073/pnas.0910684107

Cite This Page:

University of Gothenburg. "New DNA technique leads to a breakthrough in child cancer research." ScienceDaily. ScienceDaily, 22 February 2010. <www.sciencedaily.com/releases/2010/02/100222104945.htm>.
University of Gothenburg. (2010, February 22). New DNA technique leads to a breakthrough in child cancer research. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2010/02/100222104945.htm
University of Gothenburg. "New DNA technique leads to a breakthrough in child cancer research." ScienceDaily. www.sciencedaily.com/releases/2010/02/100222104945.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:  

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile iPhone Android Web
      Follow Facebook Twitter Google+
      Subscribe RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins